Get startedLog in
    Picture of Bayer AG logo

    BAYN — Bayer AG News Story

    0.000.00%
    de flag iconLast trade - 00:00
    HealthcareAdventurousLarge CapMomentum Trap
    All News

    Brief: Bayer AG - Kerendia Approved In China For New Indication In Adult Patients With Heart Failure With LVEF ≥40%

    Picture of Bayer AG logoBayer AG
    22/05/2026 07:34
    May 22 (Reuters) - BAYER AG BAYGn.DE:

BAYER AG - KERENDIA™ APPROVED IN CHINA FOR NEW INDICATION IN ADULT PATIENTS WITH HEART FAILURE WITH LVEF ≥40%

Further company coverage: [BAYGn.DE]

 (Gdansk Newsroom)

 ((Gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))

    Recent news on Bayer AG

    See all news